Michael D Stanley
CIK 1542492 · View on SEC EDGAR ↗
First SEC filing: Feb. 16, 2012 · Latest: Feb. 16, 2012
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 1, 2016 | MD | S | 14,778 | $67.78 | $1,001,653 | 35,247 Direct | -29.54% | Disposed | -61.5% (price as of 2026-08-19) |
| June 1, 2015 | MD | S 10b5-1 | 18,522 | $70.48 | $1,305,431 | 37,131 Direct | -33.28% | Disposed | -63.0% (price as of 2026-08-19) |
| June 2, 2014 | MD | S 10b5-1 | 18,006 | $57.00 | $1,026,342 | 43,902 Direct | -29.09% | Disposed | -54.2% (price as of 2026-08-19) |
| June 3, 2013 | MD | S 10b5-1 | 8,906 | $91.01 | $810,535 | 23,796 Direct | -27.23% | Disposed | -42.7% (price as of 2026-08-19) |
| Nov. 23, 2012 | MD | S 10b5-1 | 1,470 | $77.16 | $113,425 | 23,949 Direct | -5.78% | Disposed | -32.4% (price as of 2026-08-19) |
| Nov. 20, 2012 | MD | S 10b5-1 | 400 | $77.10 | $30,840 | 23,949 Direct | -1.64% | Disposed | -32.3% (price as of 2026-08-19) |
| Nov. 7, 2012 | MD | S 10b5-1 | 9,755 | $77.11 | $752,208 | 23,949 Direct | -28.94% | Disposed | -32.3% (price as of 2026-08-19) |
| June 1, 2012 | MD | S 10b5-1 | 8,649 | $59.89 | $517,989 | 23,949 Direct | -26.53% | Disposed | -12.9% (price as of 2026-08-19) |
| Feb. 27, 2012 | MD | S 10b5-1 | 4,053 | $75.50 | $306,002 | 20,725 Direct | -16.36% | Disposed | -30.9% (price as of 2026-08-19) |
| Feb. 24, 2012 | MD | S 10b5-1 | 9,800 | $75.45 | $739,410 | 20,725 Direct | -32.10% | Disposed | -30.8% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Nov. 23, 2012 | MD | Stock Options (Right to Buy) | Common Stock (1,470) | $57.09 | June 1, 2017 | 1,470 | Disposed |
| Nov. 20, 2012 | MD | Stock Options (Right to Buy) | Common Stock (400) | $57.09 | June 1, 2017 | 400 | Disposed |
| Nov. 7, 2012 | MD | Stock Options (Right to Buy) | Common Stock (9,755) | $57.09 | June 1, 2017 | 9,755 | Disposed |
| Feb. 27, 2012 | MD | Stock Options (Right to Buy) | Common Stock (4,053) | $55.43 | June 2, 2018 | 4,053 | Disposed |
| Feb. 24, 2012 | MD | Stock Options (Right to Buy) | Common Stock (9,800) | $55.43 | June 2, 2018 | 9,800 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
MD
M.D. President, Clinical Services Division| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2016 | — | — | — | — | — | — | — | — |
| 2015 | — | — | — | — | — | — | — | — |
| 2014 | — | — | — | — | — | — | — | — |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.